Information about Affinidi’s involvement in cross-border screening of travellers

Information about Affinidi’s involvement in cross-border screening of travellers

We refer to the messages being circulated about a cross-border initiative to screen travellers between Singapore and Malaysia for COVID-19.

Temasek has already stated that it has not been appointed by the Singapore Government to handle all COVID-19 screening pertaining to travellers entering and exiting the country.

Affinidi, a company founded by Temasek that helps create verifiable digital identities, and BP Healthcare Group, a swab operator in Malaysia, are working together to explore the issuance of cryptographically verifiable COVID-19 swab test results. We hope this can be used as a step to help enable safe and convenient travel.

Work is progressing well, but there are other tests and processes to work out with various stakeholders in the meantime.

More details will be shared in due course.